ENTITY

Neurocrine Biosciences (NBIX US)

36
Analysis
Health CareUnited States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Refresh
Publication Icon
No publications yet
There aren’t any broker reports right now
Back to "All"
x